SCHEMBL7801344

SCHEMBL7801344

O=C(Nc1ccc2c(c1)CNCC2)c1cccc(C2=NN2C(F)(F)F)c1

nearest known ligand 0.55

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MELK Q14680 2/20 0.55
ITGB3 P05106 5/20 0.55
ITGA2 P17301 5/20 0.55
SLC2A1 P11166 1/20 0.52
ITGA2B P08514 4/20 0.51
ROCK2 O75116 6/20 0.49
PKN2 Q16513 2/20 0.49
PRKG1 Q13976 2/20 0.49
PRKCE Q02156 1/20 0.49
CYP3A4 P08684 1/20 0.49
CYP2C19 P33261 1/20 0.49
BTK Q06187 1/20 0.47
F2 P00734 1/20 0.46
PLG P00747 1/20 0.46
PLAU P00749 1/20 0.46
PLAT P00750 1/20 0.46
KLKB1 P03952 1/20 0.46
PRSS1 P07477 1/20 0.46
NPC1 O15118 1/20 0.44
NFKB1 P19838 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4566270 0.76 MELK (0.76) MELKITGB3ITGA2SLC2A1ITGA2B
SCHEMBL29431209 0.76 MELK (0.76) MELKITGB3ITGA2SLC2A1ITGA2B
SCHEMBL7792064 0.76 ITGB3 (0.66) MELKITGB3ITGA2SLC2A1ITGA2B
SCHEMBL24892142 0.75 MELK (0.87) MELKITGB3ITGA2SLC2A1ITGA2B
Trifluoroacetic Acid SCHEMBL30182594 0.74 MELK (0.77) MELKITGB3ITGA2SLC2A1ITGA2B
SCHEMBL8189145 0.73 MELK (0.46) MELKITGB3ITGA2SLC2A1ITGA2B
SCHEMBL8197860 0.72 MELK (0.68) MELKITGB3ITGA2SLC2A1ITGA2B
SCHEMBL16168679 0.71 ROCK2 (0.68) MELKITGB3ITGA2SLC2A1ITGA2B
SCHEMBL16168735 0.71 ROCK2 (0.72) ITGB3ITGA2ROCK2PKN2PRKG1
SCHEMBL7801352 0.71 MELK (0.52) MELKITGB3ITGA2SLC2A1ITGA2B

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20010025045-A1 Substituted isoquinoline derivatives and their use as anticonvulsants SMITHKLINE BEECHAM P.L.C. 2001-09-27 US disclosed
EP-1025087-A1 SUBSTITUTED ISOQUINOLINE DERIVATIVES AND THEIR USE AS ANTICONVULSANTS SMITHKLINE BEECHAM PLC (GB) 2000-08-09 EP disclosed
WO-1999021836-A1 SUBSTITUTED ISOQUINOLINE DERIVATIVES AND THEIR USE AS ANTICONVULSANTS SMITHKLINE BEECHAM PLC (GB) 1999-05-06 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20010025045-A1 Substituted isoquinoline derivatives and their use as anticonvulsants INA, GRIN2C, GRIN2A MELK 2857/4885ITGB3 4504/4885ITGA2 4491/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.